Cosciens Biopharma, formerly Aeterna Zentaris, announces that the company’s name has been changed from “Aeterna Zentaris” to “Cosciens Biopharma,” effective as of August 6. In addition, the company announces that, effective as of August 9, the company’s common shares will begin trading on the Toronto Stock Exchange and Nasdaq Capital Market under the trading symbol “CSCI” and will concurrently cease trading thereon under the former trading symbol “AEZS“.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEZS:
- Aeterna Zentaris Release: A Technical Glitch?
- Aeterna Zentaris Wraps Up Key Pediatric Trial
- Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
- Aeterna Zentaris announces last patient last visit in DETECT-trial
- Aeterna Zentaris and Ceapro Announce Merger Completion